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Structure, function and five basic needs 
of the global health research system
Background Two major initiatives that were set up to support and 
co–ordinate global health research efforts have been largely discon-
tinued in recent years: the Global Forum for Health Research and 
World Health Organization's Department for Research Policy and Co-
operation. These developments provide an interesting case study into 
the factors that contribute to the sustainability of initiatives to sup-
port and co–ordinate global health research in the 21st century.
Methods We reviewed the history of attempts to govern, support or 
co–ordinate research in global health. Moreover, we studied the 
changes and shifts in funding flows attributed to global health re-
search. This allowed us to map the structure of the global health re-
search system, as it has evolved under the increased funding contri-
butions of the past decade. Bearing in mind its structure, core 
functions and dynamic nature, we proposed a framework on how to 
effectively support the system to increase its efficiency.
Results Based on our framework, which charted the structure and 
function of the global health research system and exposed places and 
roles for many stakeholders within the system, five basic needs 
emerged: (i) to co–ordinate funding among donors more effectively; 
(ii) to prioritize among many research ideas; (iii) to quickly recognize 
results of successful research; (iv) to ensure broad and rapid dissem-
ination of results and their accessibility; and (v) to evaluate return on 
investments in health research.
Conclusion The global health research system has evolved rapidly 
and spontaneously. It has not been optimally efficient, but it is pos-
sible to identify solutions that could improve this. There are already 
examples of effective responses for the need of prioritization of re-
search questions (eg, the CHNRI method), quick recognition of im-
portant research (eg, systems used by editors of the leading journals) 
and rapid and broadly accessible publication of the new knowledge 
(eg, PLoS One journal as an example). It is still necessary to develop 
tools that could assist donors to co–ordinate funding and ensure more 
equity between areas in the provided support, and to evaluate the 
value for money invested in health research.
In the past four years, two major initiatives that were set up with the aim 
to support and co–ordinate global health research efforts have been large-
ly discontinued. The first is the Global Forum for Health Research, which 
was established in Geneva in 1998 to support WHO’s focus on health re-
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search [1]. The second is WHO's Department for Research 
Policy and Cooperation (WHO RPC), which ceased its op-
erations in 2012 during the WHO's internal reform. Almost 
ironically, the annual WHO World Health Report for 2012 
announced its theme as: “No health without research” and 
was to be coordinated by the WHO RPC [2]. The journal 
PLoS Medicine agreed to publish a special series on health 
research in parallel to the release of the World Health Re-
port, as discussed in the journal's editorial to the series, 
entitled: “The World Health Report 2012 that Wasn’t” [3]. 
Eventually, the report was retitled “Research for Universal 
Health Coverage” and published in 2013 [4].
These developments provide an interesting case study into 
the factors that contribute to the sustainability of initiatives 
to govern, support and co–ordinate global health research 
in the 21st century. A timeline of key events that set the 
current context is shown Figure 1. In this viewpoint, we 
will map the structure of the global health research system 
as it has evolved under the funding increases of the past 
decade. Bearing in mind its structure, core functions and 
dynamic nature, we will propose a framework on how to 
effectively support the system to increase its efficiency.
THE EVOLVING STRUCTURE OF THE 
GLOBAL HEALTH RESEARCH SYSTEM
Over the past two decades, the funding available for health 
research has increased rather dramatically from US$ 50 bil-
lion in 1993 to US$ 240 billion in 2009 [5], but this did 
not happen in any planned or coordinated way. Those who 
tried tracking this funding – such as the Global Forum for 
Health Research in its annual reports, G–FINDER, the In-
stitute for Health Metrics and Evaluation and other aca-
demics, provided rather different figures [5–9]. This dis-
crepancy is largely due to the difficulty in distinguishing 
research funding from broader development assistance for 
health. There is also lack of consensus on whether the 
funding invested in high–income countries to study health 
challenges that may be relevant to low and middle–income 
countries should also be included. Still, under any assump-
tion, the interest in funding global health research is grow-
ing, and the structure of this system is rapidly evolving.
In Figure 2, we show the simplified representation of the 
key stakeholders and processes, based on how the funds 
flow through the system. At the beginning of the system is 
the source of the funding – with donors being either pub-
lic, private, or the emerging “class” of donors – the large 
philanthropies, such as the Bill and Melinda Gates Foun-
dation (BMGF), the Carlos Slim Foundation, and the Rock-
efeller Foundation. They all provide financial support for 
the projects of researchers employed in universities, re-
search institutes, international organizations, biotech com-
panies and small and medium enterprises (SME are a grow-
ing “class” of recipients). They also fund stakeholders with 
research capacity in low and middle–income countries that 
can help carry out the research projects as equal partners. 
Eventually, the responsibility for spending the funds is 
passed down to research teams and their international con-
sortia, which conduct research to generate new knowledge 
in several generic areas: measuring a problem; understand-
ing its cause(s); elaborating solutions; translating the solu-
tions or evidence into policy, practice and products; and/
or evaluating the effectiveness of solutions [10].
The decision over the channel of dissemination of this knowl-
edge is made by a new set of stakeholders (Figure 2), which 
may involve research committees of public institutions, jour-
nal editors, reviewers, donor representatives, company man-
agers or owners. The bulk of work will end up published by 
research journals, where editors and reviewers, and some-
times even private publishers, influence decisions on the 
shape and form of publication. The funders increasingly re-
quire researchers to publish in open–access journals. Some 
of the findings do not get published because placing the 
knowledge in the public domain would invalidate patent ap-
plications and subsequent financial profits. This new knowl-
edge can also be presented at conferences, published as a re-
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Figure 1. A timeline of several important events relevant to governance, support and co–ordination of global health research that 
determined the current context.
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port to the funder, as “grey literature”, or simply posted on 
the internet. Finally, in many cases, new knowledge does not 
get published in any way – perhaps due to insufficient rele-
vance or novelty, concerns over its quality, or simply a lack of 
a positive result. In the end, the published knowledge can be 
professionally evaluated and replicated, with a growing in-
dustry of companies offering those services. Moreover, uni-
versities have set up structures to help researchers to com-
mercialize their work and set up spin–out companies.
THE CORE FUNCTIONS OF THE GLOBAL 
HEALTH RESEARCH SYSTEM
There should not be much controversy over the main func-
tion of the global health research system: it is there to use 
donors’ funding to support experiments that address per-
tinent health research questions. In this way, through an-
swering those questions, new knowledge is continuously 
being generated. This knowledge is then translated into 
both clinical and public health practice in order to reduce 
the burden of disease in the population and improve 
health–related outcomes.
The effectiveness of the global health research system to 
perform its main function will depend on the efficiency of 
several of its sub–components (Figure 2). First, donors 
need to be motivated to continue investing; informed to un-
derstand the targets; and coordinated to avoid over– and 
under–funding certain areas. This, in turn, ensures effi-
ciency of their investments. Second, researchers need to 
prioritize research ideas well, to balance those that could 
benefit the public relatively soon with more speculative and 
downstream ones. They need to design and conduct the 
experiments carefully to ensure that their efforts are useful 
even when the result is negative. Third, managers, journal 
editors and media need to recognize important progress 
accurately to ensure efficiency in selection of work that re-
Figure 2. The structure of the global health research system and the five basic needs to ensure its efficient 
performance.
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ceives attention. Fourth, publishers need to ensure broad 
open access to all new knowledge that results from health 
research and rapid accessibility of information without ex-
ception. Fifth, the effectiveness of translation of the new 
knowledge into practice needs to be evaluated. This is im-
portant because it could help recognizing the most prom-
ising research projects and ideas earlier in the process. It 
would also allow comparisons of returns on investments 
in health research with other competing investments that 
could also improve health, such as development assistance, 
infrastructure projects, or simply increased purchase and 
coverage of existing interventions.
After the relatively stagnant nature of the global health re-
search system throughout most of the second half of the 
20th century, the system evolved rapidly over the past de-
cade and took a life of its own in all of its segments. At-
tempts to support and co–ordinate such a dynamic and 
unpredictably evolving system using a ‘top–down’ ap-
proach may have seemed a feasible and sustainable mission 
from the perspective of the post–World War II world, when 
the UN was established. However, the 21st century global 
health research system has developed in a “bottom–up”, 
“laissez–faire” manner, in which the stakeholders them-
selves are continuously inventing improved practices and 
introducing changes in the models that worked well in pre-
vious decades. This is happening at all levels – with emerg-
ing big donors, innovative finance mechanisms, creative 
organization of large international consortia of research 
teams and their collaborations on “big science”. There are 
now many web–based routes to publication, new tools and 
measures of assessment of research output (like Google 
Scholar, Scopus, Research Gate and H–index metric), and in-
creased support mechanisms for rapid translation, com-
mercialization and implementation of research results. In 
such a dynamic system, any attempt to influence the rele-
vant stakeholders and processes from the “outside” by a 
group of experts who drive their legitimacy exclusively 
from a fact that they are employees or affiliates of the UN 
is largely unrealistic and outdated.
FIVE BASIC NEEDS OF THE GLOBAL 
HEALTH RESEARCH SYSTEM AND 
PROPOSED SOLUTIONS TO IMPROVE 
ITS EFFICIENCY
We now propose an alternative route to improved efficien-
cy of the global health research system that would be pri-
marily needs–based, and therefore likely welcomed by the 
stakeholders in the system. At the top of Figure 2, it is clear 
that the emergence of new donors is certainly a positive 
development, but it requires their sustained motivation and 
also carries a large risk of becoming un–coordinated and 
unbalanced, with high preference towards certain topics 
and neglect of others. This is a real risk that has already 
been exposed in even the most basic analysis of funding 
flows [7]. To help the system develop and grow in an eq-
uitable way at this level, there is a need to continuously 
track funding using an internationally agreed methodology, 
preferably by more than one agency/institute. Beyond sim-
ply tracking funding, a tool is needed to ensure that no ar-
eas are neglected in comparison to areas of strong donor 
preference, thus assisting policy–makers and donor repre-
sentatives. As a possible solution, we are working to pro-
pose a “Stock Market for Global Health Research Invest-
ment Options” – a tool that would use analogy to real–time 
stock markets to compare the burden of different health 
problems with the investments being committed to those 
problems, using the most recent available information.
The main need at the level of the recipients in the system – 
the communities of researchers (Figure 2) – is to find ways 
to communicate and agree on their own field's research pri-
orities, so that a more balanced and unified case on funding 
priorities could be presented to donors from the “cutting 
edge” of research. As a possible solution, “the CHNRI meth-
od” developed by the Child Health and Nutrition Research 
Initiative (CHNRI) of the Global Forum for Health Research 
seems to be an example of this need being met rather effec-
tively [11]. This “crowd–sourcing” approach to generating 
and managing research ideas, while balancing short–term 
and long–term vision and different instruments of health 
research, has been validated through many applications 
[12–15]. The results from 50 conducted research prioritiza-
tion exercises have been published by mid–2015, and many 
further exercises are being conducted presently [15]. A re-
cent independent review showed that 18% of prioritization 
exercises in global health research in recent years used the 
CHNRI methodology, which made it the most frequently 
used specific priority–setting method [16].
Then, at the level of stakeholders who govern dissemina-
tion of research results (Figure 2), there is a need for a tool, 
process or a system that would recognize important re-
search, promote and reward it appropriately [17]. Interest-
ingly, journal editors operate such systems already while 
reaching their decisions on which papers to publish. Given 
that many of them select less than 10% of submissions for 
publication, the journals that manage to maintain high 
quality and substantial impact over time have clearly de-
veloped well–performing systems. We propose to learn 
more of their decision–making systems and processes and 
review the results of their work – both at the level of jour-
nal's impact, and of individual papers – over long periods 
of time. This should allow development of a system that 
would be highly sensitive to important research and ensure 
its publication, but also quite specific, reducing the amount 
of published work that is not relevant.
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Clearly, it is difficult to predict the impact that research ar-
ticles may have in the future at the point at which they are 
being evaluated. However, in the new world of “big data”, 
it is possible to conduct massive exercises in available da-
tabases of research papers and their received citations to 
search for common patterns that are shared among those 
papers that have most impact. Recently, the journal Nature 
devoted a special news feature to analysis of the 100 most 
cited papers of all time [18]. In a related feature, titled “Is 
your most cited work your best?”, Ioannidis et al. tried to 
capture the key dimensions that need to be addressed to 
make any biomedical research “exceptional”. They asked 
about 400 most cited biomedical scientists in the world 
(123 of whom responded) to score their 10 most cited pa-
pers from 0–100 for each of the six criteria that they hy-
pothesized may be inherent to truly exceptional work. 
They termed these six criteria “Continuous Progress, Broad-
er Interest, Greater Synthesis, Disruptive Innovativeness, 
Surprise and Publication Difficulty” [19]. Their exercise 
made some of the first steps towards a more systematic and 
transparent framework that could allow capturing the ex-
ceptional nature of biomedical research articles at the time 
they are evaluated, rather than having to wait for many 
years to determine their importance through impact they 
generated and citations they received [19].
At the next level – dissemination of new knowledge (Fig-
ure 2) – the need for broad and rapid access to new knowl-
edge is presently being addressed through the “open ac-
cess” movement, world wide web development, IT–based 
solutions for publication, dissemination and search en-
gines, social networks and internet–based media [20]. The 
success of PLoS One journal can be used as an excellent ex-
ample. We believe that the journal succeeded in a very 
short time, and well beyond expectations, precisely be-
cause it provided an effective solution to this particular 
need of the global health research system. It is enough to 
state that in the year of its inception, in 2006, it published 
137 papers; in 2007 it already published 1230 papers, and 
in 2013 a staggering 31 498 papers, with the number per 
year still growing strongly. At the same time, given an un-
precedentedly large denominator, it still manages to keep 
a very decent impact factor of around 4.0 in the past sev-
eral years. Clearly, many participants in the global health 
research system have recognized PLoS One as a solution 
that addresses one of the system's major needs.
Finally, at the level of research outputs, a tool is needed that 
could evaluate returns on investments in global health re-
search, and what is seen as the value for money gained 
through those investments [21]. The tool should also mon-
itor success rates in translation and implementation of the 
outcomes into products and programmes, all the way to 
measurable benefits for global public health. Such a tool 
would allow a proper understanding of the actual value of 
investing in health research, in comparison to alternative 
forms of investments that can also benefit health – eg, com-
munity infrastructure projects, improved education, safety, 
social welfare, and transportation. It is perhaps time to get 
some understanding on whether the many trillions invest-
ed in health research have been a reasonable investment – 
especially in the wake of Big Pharma largely closing down 
their R&D departments, which may provide an indication 
that they are concerned about the feasibility of those invest-
ments in comparison to alternatives. This need will be the 
most difficult to address, but we aim to propose a draft so-
lution and keep improving it over time.
CONCLUSION
The global health research system has evolved rapidly and 
spontaneously. It has not been optimally efficient, but it is 
possible to identify solutions that could improve this. There 
are already examples of effective responses for the need of 
prioritization of research questions (eg, the CHNRI method), 
rapid recognition of important research (eg, systems used by 
editors of the leading journals) and quick and broadly acces-
sible publication of the new knowledge (eg, PLoS One jour-
nal as an example). It is still necessary to develop tools that 
could assist donors to co–ordinate funding and ensure more 
equity between areas in the provided support, and to evalu-
ate the value for money invested in health research.
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